The new Center for Emerging and Infectious Diseases laboratory at Wayne State University School of Medicine has received Clinical Laboratory Improvement Amendments certification.
The Centers for Medicare & Medicaid Services regulates all laboratory testing (except research) performed on humans in the United States through the Clinical Laboratory Improvement Amendments. The CLIA program ensures the quality of laboratory testing and is required before a laboratory can accept human specimens for diagnostic testing.
The Center for Emerging and Infectious Diseases lab is the first instance of a CLIA certification issued for a lab specifically in WSU’s name and is one of the few CLIA-certified labs in Detroit.
“This is a big step forward for the center,” said Teena Chopra, MD, MPH, co-director of the center and medical director of the lab. “The Center for Emerging and Infectious Diseases laboratory is an essential resource for disease identification, surveillance and research, including research on the SARS-COV2 virus as well as multidrug-resistant infections.”
Hossein Salimnia, Ph.D., professor of pathology and technical director of the laboratory, the CLIA application was very well received. “This was one of the smoothest and fastest approvals I have been associated with. The lab will be used for early identification of outbreaks and infection prevention in the community, detection of new variants, and development of vaccines,” he said.
WSU received $4.3 million from the Michigan Sequencing Academic Partnership for Public Health Innovation and Response, or MI-SAPPHIRE, provided through an Epidemiology and Laboratory Capacity Grant from the Centers for Disease Control and Prevention from the United States received by the State Department of Health and Human Services.
The lab will strengthen WSU’s collaborative response to emerging and infectious diseases in partnership with the City of Detroit Health Department and the Michigan Department of Health and Human Services.